Mandal J, Jamaiyar A, Pathak S
Cureus. 2025; 17(1):e78211.
PMID: 40027027
PMC: 11872009.
DOI: 10.7759/cureus.78211.
Zhou D, Zhu X, Xiao Y
Biomark Res. 2024; 12(1):132.
PMID: 39506843
PMC: 11539471.
DOI: 10.1186/s40364-024-00679-6.
Yoon J, Oh D
Nat Rev Clin Oncol. 2024; 21(9):675-700.
PMID: 39039196
DOI: 10.1038/s41571-024-00924-9.
Duduyemi B, Asante E, Asiamah E, Afihene M
Niger Med J. 2024; 62(4):178-182.
PMID: 38694214
PMC: 11058443.
DOI: 10.60787/NMJ-62-4-33.
Xue T, Chang H, Ren M, Wang H, Yang Y, Wang B
Sci Rep. 2023; 13(1):9746.
PMID: 37328516
PMC: 10275857.
DOI: 10.1038/s41598-023-36811-z.
Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond.
Al Bitar S, El-Sabban M, Doughan S, Abou-Kheir W
World J Gastroenterol. 2023; 29(9):1395-1426.
PMID: 36998426
PMC: 10044855.
DOI: 10.3748/wjg.v29.i9.1395.
Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment.
Akinnusi P, Olubode S, Adebesin A, Nana T, Shodehinde S
Cancer Inform. 2022; 21:11769351221127862.
PMID: 36213305
PMC: 9536107.
DOI: 10.1177/11769351221127862.
Evaluation of HER2/neu expression in different types of salivary gland tumors: a systematic review and meta-analysis.
Javaheripour A, Saatloo M, Vahed N, Gavgani L, Kouhsoltani M
J Med Life. 2022; 15(5):595-600.
PMID: 35815077
PMC: 9262268.
DOI: 10.25122/jml-2021-0394.
Delivery Capacity and Anticancer Ability of the Berberine-Loaded Gold Nanoparticles to Promote the Apoptosis Effect in Breast Cancer.
Chiu C, Fu R, Hsu S, Yu Y, Yang S, Tsao T
Cancers (Basel). 2021; 13(21).
PMID: 34771481
PMC: 8582582.
DOI: 10.3390/cancers13215317.
Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer.
Guarini C, Grassi T, Pezzicoli G, Porta C
Int J Mol Sci. 2021; 22(13).
PMID: 34202896
PMC: 8268006.
DOI: 10.3390/ijms22136813.
Impact of Using Median vs. Mean in Calculating ERBB2 FISH Results in Breast Cancer.
Song J, Yu A, Munoz D, Han S, Nimmakayalu M, Hu P
Cancer Med J. 2021; 4(3):87-96.
PMID: 34095900
PMC: 8171267.
Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy.
Sun H, Chen H, Crespo J, Tang G, Robinson M, Lim B
Eur J Breast Health. 2021; 17(2):128-136.
PMID: 33870112
PMC: 8025723.
DOI: 10.4274/ejbh.galenos.2021.2021-2-9.
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status.
Nakamura K, Aimono E, Oba J, Hayashi H, Tanishima S, Hayashida T
Med Oncol. 2021; 38(4):36.
PMID: 33710417
PMC: 7954749.
DOI: 10.1007/s12032-021-01482-1.
Systematic analysis of breast atypical hyperplasia-associated hub genes and pathways based on text mining.
Ma W, Shi B, Zhao F, Wu Y, Jin F
Eur J Cancer Prev. 2018; 28(6):507-514.
PMID: 30394935
PMC: 6784767.
DOI: 10.1097/CEJ.0000000000000494.
Problems In Determining Her2 Status In Breast Carcinoma.
Pala E, Bayol U, Ozguzer A, Kucuk U, Akdeniz C, Sezer O
J Breast Health. 2017; 11(1):10-16.
PMID: 28331683
PMC: 5351527.
DOI: 10.5152/tjbh.2014.2103.
Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian Patients.
Abdel Hadi A, El Hindawi A, Hareedy A, Khalil H, Ashiry R, Elia S
Open Access Maced J Med Sci. 2016; 4(4):535-542.
PMID: 28028387
PMC: 5175495.
DOI: 10.3889/oamjms.2016.104.
Lung Cancer Biomarkers.
Villalobos P, Wistuba I
Hematol Oncol Clin North Am. 2016; 31(1):13-29.
PMID: 27912828
PMC: 5137804.
DOI: 10.1016/j.hoc.2016.08.006.
Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer.
Takahashi N, Furuta K, Taniguchi H, Sasaki Y, Shoji H, Honma Y
Oncotarget. 2015; 7(4):4925-38.
PMID: 26716644
PMC: 4826254.
DOI: 10.18632/oncotarget.6753.
Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?.
Burrai G, Tanca A, De Miglio M, Abbondio M, Pisanu S, Polinas M
Tumour Biol. 2015; 36(11):9083-91.
PMID: 26088453
DOI: 10.1007/s13277-015-3661-2.
TOP2A amplification and overexpression in hepatocellular carcinoma tissues.
Panvichian R, Tantiwetrueangdet A, Angkathunyakul N, Leelaudomlipi S
Biomed Res Int. 2015; 2015:381602.
PMID: 25695068
PMC: 4324886.
DOI: 10.1155/2015/381602.